| P50 | author | Ben Freedman | Q42397203 |
| | Gabriel Wai-Kwok Yip | Q42952251 |
| P2093 | author name string | M Li | |
| | K K Lee | |
| | Q Shang | |
| | B Tomlinson | |
| | T K Li | |
| | C-M Yu | |
| | E K Li | |
| | L Tseung | |
| | L-S Tam | |
| | V W Lee | |
| | W Pang Kuan | |
| P2860 | cites work | C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study | Q24617734 |
| | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| | Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 |
| | Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis | Q33567430 |
| | Expert consensus document on arterial stiffness: methodological issues and clinical applications | Q33999785 |
| | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 |
| | The mortality of rheumatoid arthritis | Q34338843 |
| | Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. | Q34487274 |
| | Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment | Q34561428 |
| | Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis | Q34629713 |
| | Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures | Q34647810 |
| | Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V | Q34748094 |
| | Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis | Q35552716 |
| | Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 |
| | Early vascular benefits of statin therapy | Q35574104 |
| | Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis | Q35777047 |
| | Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease | Q36014045 |
| | Accelerated atherosclerosis in rheumatoid arthritis | Q36951047 |
| | The effects of medications on myocardial perfusion | Q37232325 |
| | Infliximab improves vascular stiffness in patients with rheumatoid arthritis | Q37245192 |
| | Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors | Q37621805 |
| | Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. | Q37691140 |
| | A systematic review and meta-analysis on the therapeutic equivalence of statins | Q37747986 |
| | Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis | Q38377634 |
| | Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial | Q38398357 |
| | Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study | Q40881459 |
| | Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events | Q43656468 |
| | Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study | Q44813339 |
| | Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia | Q45086809 |
| | Simvastatin improves endothelial function in patients with rheumatoid arthritis | Q45244385 |
| | Subclinical carotid atherosclerosis in patients with psoriatic arthritis | Q46401856 |
| | Arterial stiffness in chronic inflammatory diseases | Q46505839 |
| | Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis | Q46812634 |
| | Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. | Q47959078 |
| | Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format | Q48740361 |
| | A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 |
| | Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis | Q57307089 |
| P433 | issue | 6 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| | atherosclerosis | Q12252367 |
| P304 | page(s) | 411-421 | |
| P577 | publication date | 2011-08-26 | |
| P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
| P1476 | title | Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial | |
| P478 | volume | 40 | |